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UNIT 1.4Receptor Binding Techniques
Initial interest in radioligand autoradiogra-
phy of brain tissue was driven by the potential
value of this technique in studying the in vivo
distribution of centrally acting drugs—e.g., an-
ticonvulsants and sedatives—and in evaluation
of their mechanisms of action and pharmaco-
kinetics (Roth and Barlow, 1961). A variety of
clinically useful agents had been discovered
empirically through behavioral screening, but
without clear indication as to their biochemical
actions in the brain. Subsequently, it was rec-
ognized that many drugs interacted with neuro-
transmitter receptors or other minor protein
constituents by means of stereospecific, satu-
rable binding. The in vivo distribution of radi-
oligands was then applied to detailed mapping
of the binding sites in brain (Yamamura et al.,
1974). It was later determined that in vitro
assays employing radioligands could be per-
formed for the same purpose (Young and
Kuhar, 1979). The potential advantages of the
in vitro design became immediately apparent—
e.g., the ability to directly control and measure
aspects of the binding reaction, the use of re-
duced amounts of radioligand, and the possi-
bility of employing radioligand binding to
evaluate the properties of unlabeled drugs in
competition assays.
In vitro autoradiographic binding-site as-
says are now important tools in contemporary
neuroscience and pharmacology, with
strengths and limitations that are often comple-
mentary to those of homogenate binding as-
says. Performance of rapid kinetic association
and dissociation assays and detailed multisite
saturation or competition assays can be more
difficult by autoradiography than with the use
of tissue homogenates. This is due to temporal
limitations of intact-tissue kinetics and to limits
on the number of assays that can be performed
on small structures represented in only a few
tissue sections. Conversely, the very high sen-
sitivity and spatial resolution of autoradiogra-
phy affords the ability to study structures too
small to accurately dissect for homogenate as-
says. The ability to combine binding-site
autoradiography with other anatomical imag-
ing procedures, including routine histological
staining, histochemical staining, immunohisto-
chemistry, nucleic acid hybridization assays,
and some in vivo radioligand distribution as-
says, permits powerful and flexible multidisci-
plinary protocols not possible with homogen-
ate assays. The ability to perform multiple as-
says in individual brains is an important asset
in the study of brain pathology, where subjects
may have variable severity and locations of
abnormality. Autoradiographic screening of
wide anatomic areas precludes the need to
prospectively identify all areas of potential in-
terest by gross dissection, as is necessary for
homogenate tissue assays.
Pharmaceutical development may be as-
sisted both by in vitro and in vivo ligand autora-
diography. Although in vitro methods are pre-
ferred for the detailed characterization of bind-
ing-site pharmacology, in vivo distribution
studies continue to be of use in determining the
detailed biodistributions of new drugs, afford-
ing important data on pharmacokinetics and
regional distribution in preclinical animal stud-
ies. By extension, emission tomographic imag-
ing studies of drug distribution in the living
human brain can provide important data on the
distribution and effects of novel agents both in
controls and disease states. This information
may become increasingly important in the
search for more effective drugs and in attempts
to better distinguish therapeutic effects from
unwanted side effects.
RADIOLIGAND SELECTION
Isotopic Label
Identification of candidate radioligands for
autoradiography of binding sites first necessi-
tates consideration of the possible radioiso-
topes for their labeling. The most widely em-
ployed isotope, tritium (3H), has the advantages
of low cost, ease of safe handling and disposal,
and a wide variety of approaches for introduc-
ing label into ligands. Tritium is a neutron-rich
hydrogen isotope derived from nuclear fission
reactor bombardment. It decays by the conver-
sion of a neutron to a proton with emission of
a β− particle and an antineutrino, thus increas-
ing the number of protons in the nucleus and
resulting in an atom of helium. The process of
β− emission results in a spectrum of emitted
particle energies resulting from the differential
distribution of the transition energy between
the antineutrino and the β− particle. The average
β− energy is approximately one-third of the
maximum transition energy, and in the instance
of 3H is 5.7 keV. Tritium is unique among the
isotopes employed for autoradiography since
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its average β− energy permits travel through
only a few micrometers of tissue before its
absorption (Table 1.4.1). Typical frozen histo-
logical tissue sections are much thicker than the
average 3H β− particle path length; sections of
15 to 20 µm or greater are “infinitely thick”
with respect to 3H emissions. Autoradiograms
of tritium-ligand distribution in most tissue
sections are thus insensitive to minor inconsis-
tencies in sectioning precision. The advantage
afforded by this insensitivity to tissue-section
thickness is counterbalanced by the effects of
tissue self-absorption and by the need for spe-
cialized films and emulsions for detection of
the low-energy 3H β− emissions (see discussion
of Contact Autoradiography).
As depicted in Table 1.4.1, radionuclides
employed for autoradiography differ in mode
of decay as well as in physical half-life, each
of which affect the feasibility of their use in
binding-site autoradiography. As a general
guide, if binding sites are present at an average
tissue concentration of 10 to 100 nM, a single
tritium atom per ligand molecule will permit
autoradiographic imaging with exposure times
of 5 to 7 days and specialized tritium-sensitive
X-ray films. Increasing the number of labeled
atoms per molecule or increasing the exposure
time will each independently lower the detec-
tion threshold. If the known target binding-site
density is substantially lower, use of a shorter-
half-life nuclide at higher specific activity per
labeled atom may be necessary.
The most commonly employed nuclide with
very high specific activity is iodine-125 (125I),
obtainable at almost 100-fold higher activity
per atom on the basis of its shorter half-life.
However, additional features, including abun-
dance of charged particulate emissions per de-
cay, effective film-exposure index per particle,
and the number of nuclide atoms per ligand
molecule additionally influence the relative
sensitivities of ligands labeled with 125I versus
those labeled with 3H. Labeling of ligands with
125I may be accomplished by replacement of
stable 127I or by iodination of a parent ligand at
a position distant from its site of interaction
with the binding site of interest. Iodine-bearing
ligands are often more challenging to employ
in vitro than their non-iodinated counterparts
because of the effects of increased molecular
size and greater lipophilic character conferred
by iodine. These properties tend to slow the
kinetics of ligand diffusion, binding, and dis-
sociation—and also promote increased non-
specific tissue binding when assays employ
polar, saline-based buffers. The radionuclide
decay scheme of 125I is more complicated than
that of 3H. It decays by electron capture, a
process involving absorption of an inner-shell
electron (most often a K-shell electron) by the
nucleus, which results in conversion of a proton
to a neutron with emission of a neutrino. The
orbital vacancy left by the captured electron is
then filled by an electron from a higher energy
shell, leaving the atom with excess energy. The
Table 1.4.1 Properties of Some Nuclides Useful in Autoradiography
Nuclide Emission
Max.
energy
(keV)
Avg.
energy
(keV)
Max. tissue
range (mm)
Avg. tissue
range (mm) Half-life
Max. sp. act.
(Ci/mol)
Particles per
transition
3H β−     18.6     5.7 0.008 0.004 12.3 years 2.9 × 104 1.00
14C β−  156  49 0.301 0.042 5370 years 6.7 × 101 1.00
18F β+  635 250 2.440 0.637 1.83 hr 1.7 × 109 1.00
32P β− 1710 695 8.210 2.750 14.3 days 9.2 × 106 1.00
33P β−  250  77 0.637 0.092 25 days 5.1 × 106 1.00
35S β−  167  49 0.336 0.042 87 days 1.5 × 106 1.00
99mTc ICEa  120 120 0.195 0.195 6.01 hr 5.2 × 108 0.09
123I ICEa  127 127 0.214 0.214 13.2 hr 2.4 × 108 0.14
125I AuEb   30    24c 0.019 0.012 60 days 2.2 × 106 0.20
131I β−  606 192 2.300 0.421 8.04 days 1.6 × 107 0.89
aInternal conversion electron decay.
bAuger electron decay.
cFor 125I (which exhibits Auger electron decay), the average energy is calculated from the abundance-weighted mean of electron
energies resulting from ten distinct transition possibilities with energies ranging from 22 to 30 keV.
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atom then dissipates this energy by the emission
of X rays or ejection of electrons. A given
radionuclide will emit a mix of X rays and
electrons, depending on the energy to be dissi-
pated and on the nuclear and electron compo-
sition of the atom. The X rays are termed
“characteristic X rays.” The emitted electrons,
termed “Auger electrons,” are the principal
means of autoradiographic detection of 125I.
The energy of the Auger electron is charac-
teristic of the difference in energy states of the
initial electron transition as well as the energy
of the electron absorbing the transition energy.
In the decay of 125I, Auger electrons of ten
individual energies within the range of 20 to 30
keV are emitted with a cumulative probability
of 20%. Thus, only one in five decaying 125I
atoms emit an Auger electron likely to interact
with autoradiographic film (see discussion of
Basic Autoradiographic Principles). The ener-
gies of these Auger emissions, however, are
sufficiently higher than those of 3H β− particles
so that their tissue-penetration distances are
similar to typical frozen-section thicknesses.
Also, the effective film exposure per particle is
much greater, and traditional anti-scratch-
coated X ray film can be used for autoradiog-
raphy. Overall, autoradiographic detection sen-
sitivity per 125I-decay particle may be 5- to
10-fold higher than for 3H, and when this is
combined with the differences in specific ac-
tivity and particle yield per decay, autoradiog-
raphic detection may be enhanced by 50- to
100-fold over 3H at the same tissue concentra-
tions.
Other radionuclides have been employed
successfully for autoradiography involving the
emissions of β− particles, including 14C, 32P, 33P,
35S, and 131I. Of these nuclides, all but 14C have
specific activities adequate for routine autora-
diographic imaging of low-abundance binding
sites such as neurotransmitter receptors and
transporters. The emitted energies of these trac-
ers are all high enough to penetrate typical
frozen-section tissue thicknesses well; further-
more these isotopes are not subject to tissue
self-absorption concerns and do not require
specialized films or emulsions for detection.
However, the range of ligands that can be la-
beled with these nuclides is more limited than
with 3H, based on their infrequent occurrence
in active drugs.
The β+ emitter 18F has proven useful in
positron emission tomographic (PET) imaging
of neuroreceptors and other binding sites when
incorporated in ligands to replace stable 19F,
when substituted for OH groups, or when in-
corporated in an alkyl substituent (e.g., when
employing fluoromethyl or fluoroethyl substi-
tutions for methyl or ethyl groups). The process
of β+ emission involves the conversion of a
proton to a neutron with the emission of the β+
particle and a neutrino from the nucleus. In the
instance of 18F, decay to stable 18O involves
emission of a β+ particle with maximum energy
of 635 keV, but as in the instance of β− decay,
division of energy between the β+ particle and
neutrino results in a spectrum of emitted β+
energies averaging ∼250 keV. The emitted par-
ticles are effective in exposing autoradiog-
raphic film, although they are of such high
energy that anatomic resolution is considerably
less than that typically achieved with either 3H
or 125I. An additional consideration is the ulti-
mate fate of the β+ particle, since after loss of
its initial kinetic energy it undergoes annihila-
tion with an electron in the absorbing medium
whereby the β+ particle and electron are con-
verted to 511-keV photons. These electromag-
netic radiations, indistinguishable in properties
from γ rays and X rays, require the use of
shielding in the laboratory to reduce exposure
of personnel during in vitro assays. Although
the short half-life of 18F can present challenges
in tissue processing, this isotope has been suc-
cessfully employed for ex vivo detection of
ligand distributions. It would theoretically be
possible to use 18F for in vitro assays as well if
local cyclotron and chemistry facilities for ra-
dioligand syntheses are available.
The nuclides technetium-99m (99mTc) and
iodine-123 (123I) can decay by emission of
internal conversion electrons with probabilities
of 9% and 14%, respectively, per transition.
These particles, like Auger electrons, are orbital
electrons ejected from the atom after absorbing
energy from a nuclear transition. In the instance
of 99mTc, the transition is from an excited nu-
clear energy state (a metastable excited state
denoted by the “m” in 99mTc) to a more stable
nucleus of unchanged proton/neutron compo-
sition. In ∼89% of 99mTc to 99Tc transitions,
energy is released as a γ ray of 140 keV. In one
of several alternative transition routes, how-
ever, energy is ultimately released as an internal
conversion electron of 120 keV. In the case of
123I, initial transition by electron capture results
in conversion of a proton to a neutron, and
∼14% of transitions lead subsequently to the
emission of an internal conversion electron of
127 keV that is suitable for autoradiographic
imaging. Because 99mTc is a transition metal, it
can be incorporated by chelation or coordina-
tion chemistry into organic ligands; however,
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as in the instance of iodination, the resulting
ligands generally have much larger molecular
sizes than related parent drugs. The most com-
mon autoradiographic application of 99mTc is
ex vivo imaging of cerebral perfusion on the
basis of in vivo accumulation of the tracers
[99mTc]hexamethylpropyleneamine oxime
(HMPAO) or [99mTc]N,N′′-1,2-ethylene-dibis-
L-cysteine diethyl ester hydrochloride (ECD).
Radionuclides with complicated transition
schemes—e.g., 99mTc, 123I, 125I, and 131I—most
often give rise to multiple forms of emitted
energy, including γ rays employed in medical
diagnostic imaging. While these radionuclides
are useful in tissue autoradiographic assays,
this aspect necessitates consideration of addi-
tional shielding during in vitro assays, which is
not necessary with the use of pure, low-energy
β− emitters such as 3H, 14C, 33P, and 35S.
Pharmacological and Chemical
Ligand Profiles
Ligands selected for in vitro autoradiog-
raphic assays share many characteristics with
ligands employed for homogenate binding as-
says. The most useful ligands have high affinity
for a well-defined population or populations of
binding sites, exhibit relatively low nonsatur-
able or nonspecific binding, and have kinetic
properties facilitating convenient equilibrium-
binding assay development. Generally speak-
ing, antagonist ligands that do not distinguish
different receptor states on the basis of effector
coupling provide the best tools for quantifica-
tion of binding-site numbers. As in the instance
of homogenate binding assays, ligand polarity
may influence the ability to interact with the
full tissue complement of binding sites. The use
of highly polar ligands, such as quaternary
amines, may limit detection to receptors ex-
posed on membrane surfaces, and, in intact
cells, to cell-surface receptors. Lipophilic li-
gands often detect additional binding sites pre-
sumed to reside in more lipophilic domains. In
the example of binding to intact cells, these may
include intracellular or internalized receptors.
In homogenate assays and other broken-cell
preparations, lipophilic ligands may still inter-
act with a larger number of binding sites than
polar ligands, suggesting that intramembra-
nous receptor location or adjacent lipophilic
membrane domains may be important. Ligand
polarity/lipophilicity is most readily estimated
on the basis of partitioning between aqueous
and organic phases. A widely employed system
uses octanol and saline phases. This system has
been sufficiently studied to enable the estima-
tion of the partitioning properties of new li-
gands by extrapolation from measurements
made on related compounds (i.e., from the
partitioning behavior of the parent molecular
structure and its substituents). Ligands with
octanol:saline partition coefficients less than
unity are sufficiently polar that they do not cross
cell membranes in intact cells and are likely to
detect binding sites only in hydrophilic do-
mains. Ligands with partition coefficients >10
are sufficiently lipophilic that they enter mem-
branes readily, and are likely to detect binding
sites in both lipophilic and hydrophilic do-
mains. Ligands with partition coefficients
>1000 pose additional problems in in vitro
assays, which result from nonspecific binding.
These ligands, encountered frequently among
iodinated compounds, have very poor solubil-
ity in saline-based buffers and tend to distribute
avidly into tissue sections in binding assays.
The addition of carriers in the assay buffer (e.g.,
albumin) or reduction in buffer polarity by
isoosmotic substitution of sucrose for sodium
chloride may be necessary to reduce nonspe-
cific binding in some instances.
CHARACTERIZATION OF
LIGAND-BINDING ASSAYS
General Aspects of Ligand-Binding
Autoradiography
Autoradiographic ligand assays share paral-
lel aspects of experimental design with conven-
tional in vitro homogenate binding assays, de-
scribed comprehensively elsewhere (Yama-
mura et al., 1985, 1990). A tissue source must
be selected and preprocessed, tissue samples
are incubated in the presence of labeled ligand
under carefully controlled conditions, the la-
beled tissue is washed to remove nonspecifi-
cally bound ligand, and specifically bound li-
gand is quantified. Although there are some
important distinctions between autoradiog-
raphic and homogenate studies, the princi-
ples—reversible bimolecular binding pro-
cesses as well as kinetic, saturation, and com-
petition analyses—apply equally to both
designs. In the following sections, general as-
pects and guidelines for performance of autora-
diographic assays will be considered.
Tissue Preparation
Tissues suitable for homogenate binding as-
says are usually acceptable in autoradiographic
analyses as well. In addition to specimens ob-
tained at biopsy or necropsy of experimental
animals, human surgical resection and post-
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mortem samples are often sufficiently pre-
served for autoradiography. In experimental
animal studies, simple gross organ or tissue
dissection followed by freezing is preferred.
Perfusion fixation (UNIT 1.1), while sometimes
affording improvements in histological, histo-
chemical, or in situ nucleic acid hybridization
studies, should generally be avoided in tissues
that are to be used in ligand-binding experi-
ments. Even very mild aldehyde or other tis-
sue-fixation schemes may modify kinetic and
pharmacological properties of binding sites. If
fixed tissues must be employed, it is important
to conduct all initial characterizations of the
binding site(s) in similarly processed tissues.
Effects of postmortem tissue handling and de-
lay prior to dissection and freezing can theo-
retically influence the recovery of binding sites
and other biochemical tissue markers. These
considerations are particularly important in as-
says of human postmortem tissues, where in-
tervals of many hours may pass before speci-
mens are collected. Potential postmortem arti-
facts may be reduced by careful matching of
sample histories between experimental groups.
This approach, however, does not entirely guar-
antee that important information and distinc-
tions have not been lost prior to tissue collection
and storage. An additional approach to this
problem is to conduct controlled experiments
emulating human postmortem conditions and
intervals in experimental animals, thereby per-
mitting direct assessment of possible differ-
ences between immediate and delayed tissue
dissection and freezing.
After dissection, freezing of small speci-
mens can be readily accomplished by covering
them in crushed dry ice. This method is appli-
cable to tissue blocks of up to 3 to 5 g with good
results. Blocks of considerably larger size re-
quire more efficient heat transfer during freez-
ing to avoid microscopic ice-crystal formation
or macroscopic fissuring. Large tissue blocks
should be frozen by intermittent, repetitive im-
mersion in isopentane chilled with dry ice (UNIT
1.1). Blocks should be dipped for several sec-
onds at a time, followed by withdrawal for
several seconds to permit equalization of tem-
perature between the block surfaces and center.
Otherwise, the surfaces will freeze first, and
when the center subsequently freezes and ex-
pands the tissue may fracture. Frozen tissue
blocks can be maintained for years if stored at
−70°C and protected from desiccation. Coating
the surfaces of tissue blocks with a frozen-sec-
tion embedding medium and packaging in air-
tight plastic freezer bags permits routine stor-
age with good tissue preservation and mainte-
nance of sectioning properties. Storage at
higher temperatures or repeated temperature
cycling from −70°C to cryostat-sectioning tem-
perature may hasten loss of some tissue bio-
chemical reactivities. If there is concern that
aging or repeated temperature cycling may alter
or degrade binding-site properties, this can be
explored directly in control tissues.
Tissue is prepared typically for in vitro
autoradiographic binding assays by sectioning
in a cryostat microtome (UNIT 1.1). Usual frozen-
section thicknesses of 10 to 30 µm are accept-
able for autoradiographic purposes. It is impor-
tant to bear in mind when selecting tissue-sec-
tioning conditions that generation of 3H
autoradiograms will not be appreciably af-
fected by section thicknesses within this range,
nor will section-to-section imprecision affect
the autoradiograms. However, direct scintilla-
tion spectrometry assays of sections (see dis-
cussion of Determination of Incubation and
Washing Parameters) and autoradiographic
binding assays employing radionuclides with
higher particulate-energy emissions will each
be sensitive both to the selected tissue thickness
and to the precision of sectioning. In the in-
stance of 3H autoradiography, it is typical to
collect duplicate adjacent tissue sections to
guard against the intrusion of artifacts in proc-
essing. With other radionuclides, triplicate sec-
tions should be considered, to reduce additional
section-thickness error effects, unless the mi-
crotome precision is known to be excellent.
Microtome precision can be assessed experi-
mentally by comparison of autoradiographic
densities of adjacent sections after incubation
reactions with radionuclides of moderate to
high penetration, or in ex vivo autoradiograms
after the accumulation of tracers labeled with
penetrating radionuclides. Motorized cryostat
microtomes offer the benefit of improved sec-
tion-thickness precision as compared with
manual sectioning, but are considerably more
costly than comparable manually driven mod-
els.
Tissue sections for use in autoradiographic
binding assays are usually mounted frozen on
microscope slides, thawed, and dried. Slides
should be prewashed and subbed to promote
section adhesion during binding assays. Sub-
bing solutions employing gelatin (UNIT 1.1) are
generally inferior to those containing poly-L-
lysine (see CPMB UNIT 14.1 and APPENDIX 1A in this
manual) for use in lengthy in vitro assays. High
heat conditions should be avoided during sec-
tion drying to prevent binding-site denatura-
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tion. After complete drying, slide-mounted sec-
tions may generally be stored at −70°C for up
to several weeks without loss of binding activ-
ity. If a particular binding site is known to be
fragile or is of unknown stability, effects of
post-sectioning storage should be investigated
directly in control experiments.
Detection of Specific Binding
Perhaps the most critical aspect of any li-
gand-binding assay is the detection and defini-
tion of saturable, specific binding. In the devel-
opment of new assays, considerable attention
should be focused on this aspect; when adopt-
ing assays from the published literature, it is
equally important to review results of prior
assay-development reports and give strong
consideration to replicating critical methodo-
logical experiments prior to use of the assay.
Autoradiographic assays are comparable to
homogenate binding experiments in the funda-
mentals of defining specific ligand binding.
Specific binding is by definition saturable, thus,
a minimum criterion is that the radioligand
demonstrate a component of binding that does
not increase linearly with free ligand concen-
tration. This is most easily demonstrated by the
effect of adding unlabeled ligand to the assay.
More precise pharmacological characterization
of specific binding is achievable when the ra-
dioligand and the unlabeled competitor are
chemically dissimilar, minimizing the likeli-
hood of multiple sites of overlapping tissue
interaction. It is helpful to begin the search for
specific binding of a new radioligand with
knowledge of one or more unlabeled competi-
tors of the ligand at the desired binding site as
well as the inhibitory equilibrium binding con-
stant (Ki) of each. It is best to employ an
unlabeled competitor at concentrations not
above 1000 × Ki, resulting in occupancy of
99.9% of binding sites. Use of unnecessarily
higher inhibitor concentrations increases the
possibility of detecting unwanted, secondary
sites rather than the binding site of interest. In
the sections to follow, it is assumed that a
definition of nonspecific radioligand binding
has been formulated and that its basis is the use
of a competitive inhibitor at an appropriate
concentration relative to its Ki, the radioligand
concentration, and the radioligand’s equilib-
rium binding constant (Kd).
Determination of Incubation and
Washing Parameters
After establishing an initial definition of
specific radioligand binding, it is important to
determine critical assay parameters to maxi-
mize its separation from nonspecific binding.
Preliminary studies to determine optimal incu-
bation and post-incubation washing conditions
are often performed without the use of autora-
diography for radioligand measurement. In this
instance, it is common to conduct binding stud-
ies identically to autoradiographic assays with
the exception that after post-incubation wash-
ing, sections are wiped from the microscope
slide with glass fiber filter paper and assayed
by liquid scintillation counting or by γ count-
ing, depending on the radionuclide involved. In
this way, rapid results can be obtained and
multiple potential assay modifications and re-
finements tested in logical sequence. However,
a series of tissue sections bearing reproducible
numbers of binding sites is necessary for these
assays. Even though section-thickness vari-
ation may have no effect on the autoradiog-
raphic detection of 3H, it is critical in these
direct tissue assays.
As in the case of homogenate radioligand-
binding assays, aspects of the basic binding
incubation—including choice of buffer system,
pH, time, temperature, and duration of incuba-
tion—should be explored to maximize specific
binding. Often, important initial estimates of
these quantities can be derived from prior in
vitro homogenate binding assays. It is generally
advisable in autoradiographic assays, however,
to employ incubation buffers that are isotonic,
so as to avoid osmotic stresses on tissue sec-
tions. Hypotonic buffers are particularly prob-
lematic if tissue-section adhesion is marginal,
and their use may result in tissue fragmentation
and losses from the slide.
An advantage of autoradiographic binding
assays over homogenate designs is the ability
to sample the binding incubation buffer directly
and analyze it during the course of the assay. In
the early phases of assay development, direct
measures of free ligand concentration and chro-
matography of the radioligand after tissue ex-
posure can assist with detection of unantici-
pated technical artifacts. If ligand depletion
resulting from metabolism is noted, a lower
incubation temperature should be considered.
If ligand depletion resulting from nonspecific
binding is noted, alteration of the buffer prop-
erties to promote ligand solubility may help. If
depletion is due to specific binding, the volume
of incubation buffer per tissue section must be
increased.
An initial parameter for assay optimization
is the post-incubation washing time that best
distinguishes specific from nonspecific bind-
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ing. Comparable tissue sections are usually
incubated in solutions containing labeled radi-
oligand with and without unlabeled competitor
to block specific binding. Sections are then
assayed for radioligand activity after varying
post-incubation washing times, including an
initial measurement without washing (i.e., a
“zero wash time,” or t = 0 sample). These initial
sections are processed by very brief (1 to 2 sec)
dipping in buffer lacking both the ligand and
competitor to remove binding assay buffer from
the slide surface. This step is important for
assessing the possibility of loss of labeled sites
during prolonged washing. Varying wash times
are assessed, comparing total, specific and non-
specific bindings to the initial t = 0 estimates.
Optimal post-incubation washing procedures
should reduce nonspecific binding to a mini-
mum, but not promote loss of any specific
binding detected in t = 0 samples (Frey and
Howland, 1992). Prolonged washing proce-
dures that enhance specific over nonspecific
binding, but at the expense of lost specific
binding, run the risk of preferentially revealing
a subset of binding sites. Unless the nature of
specific binding that remains versus that poten-
tially lost in these processes is understood,
experimental results may be biased and results
of studies employing distinct radioligands tar-
geting the same site(s) may be discordant.
Estimates of specific-to-nonspecific label-
ing of tissues derived from whole-section as-
says may actually provide minimum values in
comparison with autoradiographic assays
when 3H-labeled ligands are employed. This
phenomenon is due to the likelihood that wash-
ing is most effective at the section surface, and
most protracted at the section-slide interface
where the diffusion distance to reach the buffer
solution is greatest. Thus, the limited tissue-
depth penetration of 3H β− particles may result
in autoradiographic images of the most favor-
able specific-to-nonspecific binding strata.
The appropriate tissue incubation time to
achieve equilibrium in the radioligand assay
should be determined prior to conducting satu-
ration assays or other pharmacological charac-
terizations. Since the forward ligand-receptor
binding rate is a second-order process, it is
sensitive to ligand and receptor concentration
effects. The time required to achieve equilib-
rium is, therefore, a function of radioligand
concentration, and will be longest at the lowest
ligand concentration studied. Thus, it is useful
to have initial estimates of radioligand Kd (see
UNIT 7.5) so that equilibration time for ligand
concentrations below the half-maximal bind-
ing level can be safely used in saturation analy-
ses. In practice, equilibration-time determina-
tions are straightforward in design, involving
incubations of tissue with radioligand for pro-
gressively increasing durations, followed by
routine post-incubation washing and assay of
bound tracer. A caveat, however, is the possible
loss of intact binding sites in tissue sections
during prolonged incubations. This may arise,
in theory, because of solubilization of some
sites into the binding buffer. Alternatively,
losses of high-affinity ligand recognition sites
may reflect proteolytic degradation or dissocia-
tion of multiple proteins or cofactors that are
required together for ligand binding. If ligand-
binding sites are lost over the interval of the
assay, apparent equilibration may take place,
but the data will actually reflect competition
between increasing ligand binding and decreas-
ing total binding capacity (Bmax). This aspect
of ligand equilibrium can be controlled by con-
ducting parallel assays at the lowest ligand
concentration of interest and at a higher, satu-
rating concentration where binding equili-
brates more rapidly. The low-concentration
data are used to assess equilibration rate, while
lack of decrease in binding over time at the high
concentration will exclude the possibility of
binding-site losses during incubation. Desir-
able assay characteristics include incubation
times sufficiently short that no detectable losses
of binding sites occur, but which readily permit
equilibration of sub-Kd ligand concentrations.
Ligands that do not readily equilibrate at low
concentrations may, nevertheless, be useful for
assays of regional Bmax distribution alone.
However, it is recommended that use of a near-
saturating ligand concentration for this purpose
be used to guard against effects of possible
unrecognized affinity differences that cannot
be explored directly because of protracted
equilibration times at low ligand concentration.
Saturation Studies
In addition to regional mapping of ligand-
binding sites, assays to determine the pharma-
cological properties of saturable binding sites
can be conducted by quantitative autoradiogra-
phy (Penney et al., 1981). In particular, satura-
tion binding assays are indispensible for evalu-
ation of new radioligands in autoradiography.
Although in vitro homogenate binding assays
are often initial sources for selection of ligands
for autoradiographic use, it is uncommon that
kinetic association and dissociation binding
rates or the equilibrium dissociation constant
are identical in tissue homogenates and intact
Current Protocols in Neuroscience
1.4.7
Neuroanatomical
Methods
tissue sections. Some differences may relate to
a higher degree of compartmentalization of
sites in intact sections, limiting ligand diffusion
initially to a single dimension (perpendicular
to the section face). The lack of vigorous tissue
disruption in autoradiographic assays may ad-
ditionally promote maintained association of
effector coupling of other proteins with the
binding sites of interest, modifying the confor-
mation and characteristics of ligand binding.
Autoradiographic ligand-binding saturation
analyses should be designed and conducted in
parallel with in vitro homogenate assays. A
range of ligand concentrations is employed in
incubations of slides bearing a series of adja-
cent tissue sections. At each concentration, or
at regular, less frequent intervals, assessment
of nonspecific binding is made in additional
sections. A 100-fold range of ligand concentra-
tions centered on the Kd constitutes an ideal
selection for estimation of both affinity and
binding capacity. As detailed previously, it is
important to verify technical aspects of the
assay conditions so that artifacts do not result
in erroneous saturation curves. It is important
to verify by direct assay of the binding buffer
that ligand depletion has not occurred during
the incubation. It is also important that suffi-
cient time be allowed to permit equilibration of
ligand and binding sites. Each of these consid-
erations is more important the lower the ligand
concentrations used, and failure to properly
design assays will result in an underestimation
of binding. These effects result in curvilinear
Rosenthall (Scatchard) plots, mimicking ef-
fects of cooperativity at interacting binding
sites.
Competition Assays
Competition assays often require six or
more distinct incubation conditions per binding
site to assess binding affinity and capacity. In
instances of multiple receptor subtypes that are
distinguished by the competing ligand, as many
as 15 to 20 parallel conditions may be neces-
sary. Homogenate binding studies are adapted
to these designs, permitting a large number of
individual samples with highly similar tissue
and binding-site compositions. In autoradiog-
raphic assays, however, anatomic gradients and
variability from section to section make iden-
tification of truly identical tissue samples dif-
ficult. As a result, there is a methodological
trade-off between the detail of the experimental
design (number of replicate sections per condi-
tion and number of conditions) and the ability
to select sufficient adjacent tissue sections bear-
ing similar receptor types and numbers. Suc-
cess of detailed multisite competition assays is
enhanced if large, relatively invariant brain re-
gions are selected (e.g., cerebral or cerebellar
cortical regions, striatum, or major thalamic
nuclei). In order to guard against unanticipated
anatomic receptor gradients, repetition of the
total binding condition (absence of competitor)
should be performed at regular anatomic inter-
vals throughout a series of sections. If the total
binding does not change over the anatomic
extent of the sections, differences may be safely
ascribed to effects of the competitor. If subtle
gradients in total binding are detected, it may
be possible to interpolate between the control
sections and use an adjusted Bmax for each
anatomic level.
QUANTIFICATION OF LIGAND
BINDING
Basic Autoradiographic Principles
Quantitative receptor autoradiography is a
logical extension of qualitative autoradiog-
raphic techniques developed in the 1950s and
1960s for localization of radioactive tracers in
tissue specimens (see Rogers, 1979, for re-
view). All these techniques are based on the
apposition of a photographic film or emulsion
to materials containing a radioactive source.
The passage of charged particulate emissions
such as electrons, β−, and β+ particles through
the silver halide crystals of photographic emul-
sions results in the conversion of silver ions to
metallic silver. During development, these me-
tallic silver ions catalyze the transformation of
whole silver halide crystals into metallic silver,
with consequent opacification of the emulsion.
While electromagnetic radiation in the form of
γ rays, X rays, or annihilation photons is also
capable of exposing X-ray film, direct interac-
tions between these radiations and photo-
graphic emulsions are much less efficient than
those involving charged particulate emissions.
Thus, little if any contribution to tissue autora-
diography with the radionuclides discussed
previously is attributable to γ- or X-ray emis-
sions.
Numerous factors influence the response of
autoradiographic emulsions to a radioactive
source. These include the type of ionizing ra-
diation emitted by the source, the energy of the
ionizing particles, the thickness of the speci-
men containing the radioactive source, the dis-
tribution of radioactivity within the specimen,
the distance from the specimen to the emulsion,
the thickness of the emulsion, and the density
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of silver halide crystals within the emulsion. In
quantitative receptor autoradiography, many of
these issues are not a major concern as long as
experiments are performed in a standardized
manner.
Contact Autoradiography
The ligand–binding site interaction and the
radionuclide employed impose technical con-
straints in autoradiographic binding studies.
The reversible binding of most radioligands
means that exposure to aqueous solutions after
completion of the binding assay may result in
unwanted losses in both the amount and
anatomic localization of bound ligand. This
means that the traditional method for detection
and high-resolution localization of labeled
macromolecules (proteins labeled by amino
acid incorporation or nucleic acids labeled by
incorporation of labeled nucleotides)—i.e.,
dipping slide-mounted specimens directly in
liquid photographic emulsions, may result in
migration or loss of label in binding-site autora-
diography. As a result, methods have been de-
veloped to allow dry contact between labeled
tissue sections and autoradiographic emulsions
(Roth and Stumpf, 1969). In the first technique,
which is an extension of the traditional emul-
sion-dipping method, acid-washed coverslips
may be coated with an appropriate nuclear
emulsion. Coverslips are dried, affixed to mi-
croscope slides bearing the labeled tissue sam-
ple fixed at one end with contact cement, and
then fastened with a removable clip at the op-
posite end, apposing the emulsion to the sec-
tions. After exposure, the clips are removed and
the coverslips are gently raised from the tissue
opposite the side of permanent attachment, to
permit development and fixation of the emul-
sion.
The more popular and more readily quanti-
fiable autoradiographic method is to appose
tissue sections to an appropriate acetate-backed
film. Using double-sided tape or contact ce-
ment, sections on microscope slides or
coverslips are mounted on paper or cardboard
and placed in a rigid, light-tight cassette. Film
is placed immediately on top of the sections and
the cassette sealed. The cassettes are stored in
a cool, dry environment for an appropriate
period, and then the film is removed and devel-
oped. In this design, technical aspects of autora-
diogram generation are simplified; however,
the structural registration of the image with
corresponding tissue sections is less precise
than with the emulsion-dipping or coverslip-
apposition techniques.
In film-contact autoradiography applica-
tions, the radionuclide used has a marked influ-
ence on the choice of film and subsequent data
analysis. By far the most common radionuclide
is the β− emitter 3H, on the basis of its pre-
viously-discussed favorable properties (see
discussion of Isotopic Label). The relatively
low energy of its β− emissions means that these
emissions travel shorter distances both through
tissue sections and within film emulsions, ne-
cessitating specialized autoradiographic tech-
niques. Typical photographic and autoradiog-
raphic films are protected by a gelatinous “anti-
scratch” layer overlaying the silver halide
matrix, which is designed to reduce mechanical
damage as well as chemographic and contact-
induced silver reductions. In the instance of 3H,
these protective layers are too thick for β−
particles to effectively penetrate them, and the
resulting autoradiographic sensitivity is ex-
tremely low. Thus, specialized autoradiog-
raphic films lacking the protective antiscratch
layer are necessary for contact autoradiogra-
phy. These films are more costly than conven-
tional X-ray or other photographic films useful
in autoradiography of higher-energy emitters,
and must be handled with great care to prevent
mechanical damage and exposure of the emul-
sion. Additional consideration must be given to
the possibility of direct chemical interactions
between these emulsions and the section and
slide, as is also possible with liquid-emulsion
and dipped-coverslip autoradiography. While
specialized tritium-sensitive films will cer-
tainly work with 14C, 35S, and 32P, use of such
film in detection of the higher-energy emis-
sions of these isotopes is unnecessary. Conven-
tional X-ray films or finer-grained mammogra-
phy films work well for these radioisotopes; the
finer-grained emulsions afford optimal
anatomic resolution with 14C and 35S, but at the
expense of longer exposure times.
Film Densitometry and Radioligand
Quantification
Data analysis by film densitometry has be-
come straightforward through the availability
of commercial computer-assisted densitomet-
ric systems. The relative ease of quantitative
densitometry conceals some potential pitfalls
in the analysis of autoradiographic data. It is
important to recall that the relationship between
incident-radiation exposure and optical density
on developed film is not linear over an indefi-
nite range of exposures. At higher levels of
exposure, optical density reaches a ceiling (film
saturation) beyond which it no longer reflects
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additional incident-radiation exposure. Even
before saturation is reached, the relationship
between exposure and film optical density de-
viates significantly from linearity, with reduced
resolution of differences in incident-radiation
intensity. It is important to prepare and analyze
autoradiograms under conditions in which
there is a strong relationship between incident-
radiation exposure and developed-film optical
density. This precaution necessitates careful
attention to the duration of film exposure and
uniformity of development conditions.
A related problem is that of radioactivity
standards. To perform truly quantitative recep-
tor autoradiography, tissue sections must be
coexposed together with standards that provide
an external reference for the relationship be-
tween radiation exposure and film optical den-
sity. Originally, investigators prepared their
own standards by labeling brain paste homo-
genates (Freygang and Sokoloff, 1958; Pan et
al., 1983) or plastics with known amounts of
radioisotopes (Reivich et al., 1969; Pan et al.,
1983). Plastic standards are now commercially
available and widely used; they include exam-
ples of several radioisotopes used in receptor
autoradiography. Standards containing short-
lived radioisotopes must be replenished and
recalibrated frequently. This is true even for 3H
standards if they are to be used over a period of
years. Standards for 14C have the advantage of
not requiring recalibration because of the very
slow rate of decay, and can be cross-calibrated
against other radioisotopes to provide a univer-
sal set of standards. This concept, however, has
been challenged by evidence that 14C and 3H
plastic standards may not always produce par-
allel optical-density changes. In the authors’
experience, this may occur when film reciproc-
ity is violated in either of two ways. If the
intensity of one, but not both, of the exposures
has saturated, the exposures will no longer vary
proportionately. In the instance of 14C and 3H,
most film emulsions permit 14C access to
deeper levels, resulting in higher maximal op-
tical density and later saturation than with 3H.
Additionally, if exposure times are very pro-
tracted (more than several months), fading of
the latent images resulting from 14C and 3H may
occur at distinct rates that are due to differing
degrees of lattice distortion produced by depo-
sition of high versus low β− particle energies.
Good correlations between relative 14C and 3H
exposures are obtained if films are exposed for
less than 3 months time and if care is taken to
avoid saturation of the 3H exposure. In addition,
14C standards have been used to control for
exposures arising from 18F (Olds et al., 1985),
35S, 99mTc (Taylor et al., 1992), 125I, and 123I.
On the basis of these experiences, it may be
predicted that extension of this method of
standardization to other nuclides listed in Table
1.4.1 should also succeed.
Another important consideration in the in-
terpretation of [3H]ligand autoradiography is
that differential absorption of emissions within
tissue, known as tissue quenching, may alter
imaging results. In brain tissue, lipid-rich white
matter absorbs 3H emissions to a greater extent
than gray matter. This absorption differential
gives rise to apparent ligand-concentration dif-
ferences between brain regions that may in part
reflect differing gray versus white–matter com-
positions. This effect may confer as much as a
2-fold difference in the autoradiographic image
exposures of comparably labeled gray and
white–matter structures (Geary and Wooten,
1985). Differential effects of 3H quenching may
be advantageous for anatomic localization of
binding signals through contrast-enhancing ef-
fects. However, in between-group experimen-
tal comparisons, alterations in tissue composi-
tion rather than binding-site numbers may con-
found autoradiogaphic measures.
Three approaches have been employed to
address the 3H quenching problem. One design
is to determine the relative changes in a refer-
ence binding site (a “control” site known to be
experimentally unaffected) in comparison to
the binding site of interest. If both sites appar-
ently change by the same fraction between
experimental groups, altered tissue composi-
tion is the most likely explanation. Some
groups have developed procedures to eliminate
lipids from dried tissue sections, thus, eliminat-
ing the major source of regional quenching
differences (Happe and Murrin, 1990). Unfor-
tunately, most delipidation procedures result in
denaturation or loss of ligand-binding sites.
The final approach to evaluating and cor-
recting for differential quenching effects is to
make direct measures of attenuation of a dif-
fusely introduced label in parallel sections to
those in the binding assays. For example, ter-
minal in vitro labeling of proteins followed by
their autoradiography has been employed suc-
cessfully for analysis and correction of tissue
quenching effects (Smith et al., 1995). Quench-
ing is not a significant source of bias or error in
typical 20-µm-thick tissue sections when la-
beled with the higher-energy-emitting radionu-
clides.
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ANALYSES OF
AUTORADIOGRAPHIC DATA
Anatomic Distribution
Interpretation of autoradiograms requires
the ability to identify reliably the correct re-
gions of interest. Regional anatomy can be
identified in several complementary ways. The
most direct of these is use of the autoradiogram
itself. With many ligands, there is sufficient
detail and contrast in the images to establish
regional boundaries, even for small regions.
Fiber tracts typically express low levels of sy-
naptic binding sites, and in the instance of
tritium-labeled ligands, the higher lipid levels
of fiber tracts will further reduce emulsion
exposure (see discussion of quenching under
Film Densitometry and Radioligand Quantita-
tion). Consequently, structures such as the cor-
pus callosum, the deep cerebellar white matter,
the internal capsule, and and other myelinated
fiber tracts are identified readily and may serve
as anatomic landmarks for structural identifi-
cation. Many binding sites also have regional
gray-matter distribution patterns that permit
ready identification of selected regions. For
example, the striatal complex expresses
uniquely high levels of several neurotransmit-
ter receptors, including dopamine D1 and D2
receptors and adenosine A2 receptors, while
cannabinoid receptors are expressed at very
high levels within the globus pallidus (Herken-
ham et al., 1990). Autoradiograms of binding
sites with more widespread patterns of expres-
sion—e.g., GABAA (Pan et al., 1983), excita-
tory amino acid (Greenamyre et al., 1985), or
muscarinic cholinergic receptors (Wamsley et
al., 1980)—often contain sufficient regional
variation in expression levels to permit accurate
identification of regions.
Conventional histology can also be used to
guide interpretation of autoradiograms. Sec-
tions exposed to film can be processed sub-
sequently for Nissl staining (see discussion of
Combination with Other Anatomic Methods)
and then used for regional anatomic identifica-
tion. Some image-processing systems (e.g., the
MCID System family from Imaging Research;
see SUPPLIERS APPENDIX) support parallel process-
ing and analysis of multiple images, allowing
superposition of Nissl-stained sections and
autoradiograms and direct transposition of
structural boundaries from the histologic to the
binding images. Sections immediately adjacent
to those chosen for autoradiography can alter-
natively be used for histology. In addition to
conventional histological tissue staining, sec-
tions can be processed for histochemistry or
other techniques that may reveal boundaries or
tissue distinctions not appreciated with conven-
tional histology.
Saturation and Competition Isotherms
Analyses of binding curves to estimate af-
finities and densities of sites are identical to the
post-processing analyses conducted on data
from in vitro homogenate binding studies. As
mentioned previously, care should be taken to
assure that radioligand Kd estimates used to
make estimations of unlabeled ligand Ki values
are appropriate to intact tissue sections (see
discussion of Detection of Specific Binding).
Ideally, all important binding parameters would
be determined in each individual brain and
region studied. This is often impractical, how-
ever, and Kd values determined in repre-
sentative samples of an experimental group
must often be extrapolated to regional mapping
and unlabeled ligand competition experiments
performed in other brains. Computer-assisted
analyses (Munson and Rodbard, 1980) are of
particular value when multiple binding-site es-
timations are undertaken to assure that unbi-
ased parameter estimates are made and to per-
mit proper statistical comparisons of alternative
binding models. With typical autoradiographic
measurement variances and difficulties in as-
suring stable anatomic receptor expression
throughout a large series of adjacent tissue
sections, it is unusual to identify and separate
more than two sites in most binding experi-
ments (Frey and Howland, 1992).
Combination with Other Anatomic
Methods
Receptor autoradiography can be combined
with almost any neuroanatomical method for
which tissue preparation is compatible with
receptor studies, using alternate sections de-
rived from the same blocks of tissue for indi-
vidual assays. Unfixed, frozen tissue sections
can be used in a wide variety of neuroanatomic
methods. In addition, some comparison meas-
ures can be made on the same tissue sections
used for receptor autoradiography. Routine his-
tology with Nissl staining is readily accom-
plished on sections used for receptor binding
after film exposure, by post-fixing the sections
over paraformaldehyde vapors. Sections are
placed in a tightly sealed container in a rack or
on a platform suspended above paraformalde-
hyde powder. The sections are exposed to para-
formaldehyde vapors by warming of the cham-
ber for a minimum of 48 hr, and then stained
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with 0.5% cresyl violet in the conventional
manner (see UNIT 1.2). This method produces
sections with excellent regional histology and
surprisingly good preservation of perikaryal
cellular morphology. The quality of these sec-
tions is more than adequate to establish regional
boundaries and to confirm the presence of ex-
perimental lesions or cannula placements.
Another technique that can be readily com-
bined with receptor autoradiography and that
can employ either identical or alternate sections
is [14C]2-deoxyglucose (2DG) autoradiogra-
phy of cerebral glucose metabolism (Sokoloff
et al., 1977). The same tissue sections utilized
for 2DG studies can be processed for receptor
autoradiography after the metabolic autora-
diograms are initially obtained, or, more often,
adjacent sections from [14C]2DG-labeled
brains can be processed for ligand binding and
autoradiograms exposed in parallel. The latter
design is favored, since rapid desiccation of
tissue sections on a slide warmer enhances the
anatomic resolution of the 2DG method, but
may diminish the recovery of binding sites. In
any event, it is important to incorporate addi-
tional prewashes into the receptor autoradiog-
raphy protocol to completely remove the
[14C]2DG from the tissue prior to binding as-
says with lower-energy radionuclides.
A number of additional techniques can be
applied to alternate sections harvested during
cryostat sectioning. Many histochemical tech-
niques can be applied to fresh-frozen tissue
sections. While somewhat lacking in cellular
resolution, histochemistry on fresh-frozen sec-
tions can give valuable information about re-
gional anatomy. Some investigators, for exam-
ple, have used cytochrome oxidase histochem-
istry on fresh-frozen sections to estimate the
extent of experimental lesions (Gonzalez and
Garrosa, 1991). It is also possible to quantitate
the intensity of many histochemical reaction
products with densitometric methods analo-
gous to those used for receptor autoradiograms.
The absence of fixation eliminates a confound-
ing variable for measurement of reaction-prod-
uct density and can allow at least semiquanti-
tative estimation of enzyme activity. Some in-
vestigators have developed methods to produce
enzyme activity standards that can be processed
in parallel with fresh-frozen tissue sections to
yield a densitometric equivalent of using solu-
tion histochemistry to estimate enzyme activity
(Biegon and Wolff, 1985).
Another useful neuroanatomical method
that can be employed in fresh-frozen sections
is in situ mRNA hybridization (see CPMB
Chapter 14 and UNIT 1.3 in this manual). Use of
this technique together with receptor autora-
diography on alternate sections allows comple-
mentary evaluations of regional mRNA and
protein expressions; the ligand-binding assay
provides the index of gene expression.
Tissue preparations for receptor autoradiog-
raphy and immunohistochemistry are not gen-
erally compatible. Fixation necessary for the
optimal visualization of many antigens often
makes receptor autoradiography impossible.
There are, however, some exceptions. Some
proteins, such as the reactive astrocyte marker
glial fibrillary acidic protein (GFAP; see UNIT
3.5), can be visualized by immunohistochemis-
try following alcohol or acetone post-fixation
of fresh-frozen sections (also see UNIT 1.2). Fur-
ther experimentation may expand the range of
neuroanatomical methods compatible with re-
ceptor autoradiography.
Three-Dimensional Reconstructions
An emerging technique, developed initially
for analysis of image data from positron emis-
sion tomography (PET) of blood flow in the
human brain, involves the analysis of binding-
site distribution data throughout the entire brain
volume at high resolution (Frey et al., 1996).
This approach has been explored for its exten-
sion to experimental-animal autoradiographic
imaging, with encouraging preliminary results
after reconstructions of the entire brain from
autoradiograms at regular intervals (Kim et al.,
1994). Screening of the entire neuroaxis with-
out the need for predefined regions of interest
or preconceptions regarding regional bounda-
ries may permit detection of unanticipated focal
changes or of significant gradients within larger
regions, which are not evident in qualitative
examinations of autoradiograms. Conversely,
these parallel analyses of large numbers of
independent regions (voxels) require conserva-
tive statistical adjustments against false-posi-
tive results that may limit detection sensitivity.
Experimental designs that employ limited
numbers of a priori regional hypotheses, but
which additionally include omnibus whole-
brain survey techniques, may afford the great-
est overall utility.
CONCLUSION
Ligand-binding autoradiography is a pow-
erful technique with many strengths and advan-
tages. Unlike most neuroanatomic techniques,
it is readily quantifiable and provides numerical
data that can be subjected to parametric statis-
tical analyses. In addition to providing maps of
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binding-site distribution, it can also yield data
about binding-site pharmacology and regula-
tion that is often comparable to that obtained
from homogenate binding techniques with less
anatomical resolution. While receptor autora-
diography does not typically provide cellular-
level resolution, it can provide excellent reso-
lution on a brain-regional basis; with careful
technique and selection of ligands it can distin-
guish and quantify small nuclear regions and
subregions. Binding-site autoradiography is
also very efficient with respect to numbers of
experimental subjects needed in assays.
Autoradiography often permits analyses of
small brain structures that would require pool-
ing of tissue from several subjects to obtain
sufficient tissue for homogenate assays. Fur-
thermore, it is technically easier to screen the
entire neuroaxis in autoradiographic assays
than to dissect and analyze a comparable num-
ber of discrete regions by homogenate binding
methods. Tissue harvested for receptor autora-
diography may also be used for routine histol-
ogy, in situ mRNA hybridization, and histo-
chemical techniques—allowing use of tissues
for multiple complementary analyses.
Autoradiography provides unique informa-
tion about the regional distribution of binding
sites and may allow identification of otherwise
unsuspected anatomical boundaries. The exist-
ence of striatal “patches” or “striosomes,” for
example, was documented first with µ-opiate
receptor autoradiography (Herkenham and
Pert, 1981). Many other neuroanatomical
boundaries and features are characterized by
unique patterns of expression of receptors and
other binding sites. The quantifiability of li-
gand-binding autoradiography also permits the
documentation of more subtle changes such as
subregional gradients of binding-site expres-
sion that may not be qualitatively obvious.
The association of specific populations of
binding sites with specific populations of neu-
rons or nerve terminals allows use of receptor
autoradiography as a quantitative measure of
the integrity of these neuronal elements. Ligand
binding to the dopamine transporter or vesicu-
lar monoamine transporter, for example, have
become standard techniques for assessment of
the integrity of nigrostriatal dopaminergic ter-
minals (Vander Borght et al., 1995). Receptor
autoradiography is an established tool in ex-
amination of normal human neuroanatomy and
in the characterization of neuropsychiatric pa-
thologies. Benzodiazepine receptor autora-
diography, for example, has been used to quan-
tify neuronal losses in human temporal lobe
epilepsy (Burdette et al., 1995). Receptor
autoradiography in human postmortem tissue
can be used to investigate the pharmacology of
human binding sites, evaluate the fidelity of
animal models of human disease states, and
guide the selection of candidate probes for PET
or single photon emission computed tomogra-
phy (SPECT) studies of the living human brain.
Finally, the general method of receptor
autoradiography can be applied to almost any
ligand-binding-site interaction with suitable li-
gands and binding kinetics. Originally devel-
oped for analysis of neurotransmitter receptor
populations, ligand-binding autoradiography
is now employed routinely to study plasma
membrane neurotransmitter reuptake trans-
porters, synaptic vesicular neurotransmitter
transporters, receptor–G-protein coupling, and
biochemical second-messenger and ion-chan-
nel modulating effects of neurotransmitters, as
well as enzyme expressions. The advantages of
high anatomic resolution and robust quantifi-
ability ensure that the autoradiographic ap-
proach will continue to provide valuable tools
for future neuroscientific research.
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